PD 166285 is a synthetic organic compound and a broad-spectrum, ATP-competitive tyrosine kinase inhibitor designed to interfere with protein tyrosine kinases involved in cell signaling pathways associated… Read more
PD 166285 is a synthetic organic compound and a broad-spectrum, ATP-competitive tyrosine kinase inhibitor designed to interfere with protein tyrosine kinases involved in cell signaling pathways associated with cancer. Because this compound is used in research and drug development, pharmaceutical laboratories require high-quality reference standards to ensure rigorous analytical testing and method validation. The PD 166285 category includes related compounds such as pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled standards. These materials are essential for accurate impurity profiling and quantitative analysis, enabling researchers to maintain precise quality control throughout the development and manufacturing processes. By providing reliable reference materials, these products support the characterization of the active pharmaceutical ingredient and help analysts achieve consistent, reproducible results in their investigations into kinase inhibition and therapeutic applications.